PRTC Stock Summary and Trading Ideas (Puretech Health PLC - American Depositary Shares | NASDAQ:PRTC)

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Puretech Health PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol PRTC.

As of December 22, 2025, PRTC stock price climbed to $17.37 with 992 million shares trading.

PRTC has a market cap of $419.81 million. This is considered a Small Cap stock.

In the last 3 years, PRTC traded as high as $38.49 and as low as $13.30.

PRTC has underperformed the market in the last year with a price return of -17.6% while the SPY ETF gained +18.8%. However, in the short term, PRTC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.2% vs +3.5% return in SPY. But in the last 2 weeks, PRTC shares have been beat by the market, returning -3.8% compared to an SPY return of +0.2%.

PRTC support price is $16.34 and resistance is $17.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRTC shares will trade within this expected range on the day.